ZUCCHINI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 4.613
EU - Europa 1.825
AS - Asia 644
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.091
Nazione #
US - Stati Uniti d'America 4.599
PL - Polonia 632
CN - Cina 451
RU - Federazione Russa 307
UA - Ucraina 267
IT - Italia 186
TR - Turchia 165
DE - Germania 163
GB - Regno Unito 135
FI - Finlandia 57
SE - Svezia 33
FR - Francia 15
AT - Austria 14
CA - Canada 13
VN - Vietnam 10
BE - Belgio 8
IR - Iran 7
IN - India 3
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
KR - Corea 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
EG - Egitto 1
IE - Irlanda 1
JP - Giappone 1
LB - Libano 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 7.091
Città #
Fairfield 683
Woodbridge 645
Warsaw 632
Houston 378
Ashburn 370
Chandler 350
Jacksonville 312
Ann Arbor 256
Seattle 256
Wilmington 243
Cambridge 198
Beijing 142
Nanjing 106
Izmir 102
Ferrara 78
Princeton 71
New York 58
San Diego 56
Milan 48
Shanghai 43
Boardman 38
Washington 34
Nanchang 25
Munich 23
Hebei 21
Jiaxing 17
Norwalk 16
Shenyang 16
Auburn Hills 14
Vienna 14
Dearborn 13
Falls Church 13
Los Angeles 13
Mcallen 13
Montréal 12
Tianjin 12
Bremen 11
Mountain View 11
Changsha 10
San Mateo 9
Dong Ket 8
Ningbo 8
Redwood City 8
Ardabil 7
Brussels 7
Jinan 7
Kunming 7
Hangzhou 6
Zhengzhou 6
Bologna 5
Guangzhou 5
Arezzo 4
Augusta 4
Philadelphia 4
Phoenix 4
Taizhou 4
Changchun 3
Ferrara di Monte Baldo 3
Indiana 3
Lanzhou 3
Leawood 3
Monmouth Junction 3
Orange 3
Pieve Emanuele 3
Pisa 3
Redmond 3
Verona 3
Addison 2
Chiswick 2
Des Moines 2
Hounslow 2
Kilburn 2
London 2
Molinella 2
Pune 2
Sofia 2
Auckland 1
Belgrade 1
Cagliari 1
Calderara Di Reno 1
Carros 1
Castelfranco Emilia 1
Chuxiong 1
Cotriguacu 1
Cuauhtémoc 1
Doncaster 1
Dublin 1
Dueville 1
Eden Prairie 1
Edmonton 1
Frankfurt am Main 1
Gallo 1
General Trias 1
Haikou 1
Hanoi 1
Hefei 1
Helsinki 1
Imola 1
Islington 1
Jinhua 1
Totale 5.531
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 406
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 302
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 281
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 257
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 250
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 154
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 135
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 130
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 127
Personalized needles for microinjections in the rodent brain 123
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 119
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 118
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 118
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 118
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 116
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 115
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 113
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 113
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 112
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 112
null 111
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 110
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 109
Involvement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. 109
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 109
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 108
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 106
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 106
Fibroblast Growth Factor-2 (FGF-2). 103
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 102
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 102
Mechanisms of action of CHF3381 in the forebrain 99
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 97
null 97
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 96
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 95
null 94
null 94
null 93
null 92
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 90
null 89
null 89
null 89
Gene Therapy Tools for Brain Diseases 89
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 86
Temporal lobe epilepsy model, neural stem cells and gene therapy 82
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 81
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 79
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 74
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 70
Different patterns of induction of FGF-2 and BDNF mRNAs during kindling epileptogenesis, and development of a herpes simplex vector for FGF-2 gene transfer in vivo. 66
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 63
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 63
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 61
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 61
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 58
Gene therapy of the nervous system by herpes virus vectors 55
Implication of sestrin3 in epilepsy and its comorbidities 54
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 53
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 44
null 43
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 37
Molecular approaches to inhibit HIV-1 tat expression and functions 33
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 30
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 24
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 24
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 23
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 22
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 19
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 17
Possible Approaches of Gene Therapy of AIDS. 14
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 13
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 13
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 11
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 10
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 9
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 7
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 4
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 2
Totale 7.202
Categoria #
all - tutte 24.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 998
Totale 25.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019586 0 0 0 0 0 0 0 0 0 0 230 356
2019/20201.776 256 81 88 230 127 185 140 172 137 172 137 51
2020/20211.016 85 115 55 99 53 100 43 113 38 157 113 45
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023749 75 46 48 80 120 102 39 77 103 4 40 15
2023/2024748 42 46 42 12 50 226 89 97 66 63 15 0
Totale 7.202